FDA to Review 7 Peptides for Compounding List in July 2026: BPC 157, Semax, Epitalon, and More HealingMaps Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law Unauthorized injectable peptide drugs seized and sold by Canada Peptide may pose serious health risks Canada.ca In 2023, the FDA deemed 19 peptides too unsafe to be dispensed by compounding pharmacies. Now, under RFK Jr., the agency is poised to reverse itself despite the fact that few The FDA has issued warning letters to multiple companies marketing compounded Retatrutide, an investigational drug from Eli Lilly still in Phase II trials. While early studies have shown promising weight loss results, Retatrutide